Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
about
Antimotility agents for chronic diarrhoea in people with HIV/AIDSSystemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adultsAvicenna's View on the Etiologies of Intestinal ObstructionEvolving paradigms in the treatment of opioid-induced bowel dysfunctionMilk Intolerance, Beta-Casein and LactoseClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionTreatment of opioid-induced gut dysfunctionVgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Recovery of gastrointestinal function with thoracic epidural vs. systemic analgesia following gastrointestinal surgery.Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsmicro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity.General anesthesia and altered states of arousal: a systems neuroscience analysis.Recent advances in the use of opioids for cancer painPromotility medications--now and in the future.Methylnaltrexone in the treatment of opioid-induced constipationOpioid receptors in the gastrointestinal tract.Diagnosis and treatment of chronic constipation--a European perspective.Drug management of visceral pain: concepts from basic research.Alvimopan, a selective peripherally acting mu-opioid antagonist.Alvimopan for the management of postoperative ileus.Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement.Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.Effects of methylnaltrexone on guinea pig gastrointestinal motility.Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice.Emerging drugs for postoperative ileus.New approaches to the treatment of opioid-induced constipation.Validated tools for evaluating opioid-induced bowel dysfunction.Opioid-induced bowel dysfunction: pathophysiology and management.Drug discovery approaches to irritable bowel syndrome.An Ecological Study of the Association between Opiate Use and Incidence of Cancers.Gastrointestinal dysmotility disorders in critically ill dogs and cats.Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway.Inhibiting roles of berberine in gut movement of rodents are related to activation of the endogenous opioid system.Mu and delta opioid receptor knockout mice show increased colonic sensitivity.Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.Assessment of intestinal peristalsis in vitro
P2860
Q24240888-462C772F-A21C-4141-864C-E157AA94A669Q24242508-A14A0317-DD88-4200-B3A0-A566F3088CA5Q26750621-DD812575-3F54-4077-833E-1549942DD5D5Q26777692-4C5B005A-0799-4F03-BD89-DC5AC56FCCA6Q26781308-26BFAB2C-4793-4AE0-97C9-9AADAF099E23Q26995944-66900B40-70C3-4494-89CF-41B4852EFB0BQ28284578-FA2AEAF6-304E-4782-B2E3-3AC147BCE170Q33296232-BBEAD081-AB17-40BB-9F02-492B5E3FD742Q33462392-11D79A02-68E9-4A02-8366-87E370F03FEDQ33702325-6EDAE97F-98D4-421E-9FB9-B554123B4205Q34085287-2B05E365-FA7D-432D-AA6E-AAEE0C9BD7BEQ34179988-680B6B11-B64A-42CF-9E43-71827C30CC91Q34418203-DA553880-6628-47B0-B4AC-02A7DC07E2A0Q34548916-F03A86AD-3E4E-4D3C-8B10-2A1E1CC71708Q35026245-C6356477-1B65-4615-B22D-919A1A0231D2Q35185222-74FBCAAC-F15A-49E5-8640-B336C513D47BQ35207439-02D50942-AAAB-4BD8-B47D-FDC92B619291Q35947915-008FE1DF-F66A-4DF7-AB10-FABF03372ED2Q36078760-40C18A69-BF91-4014-A493-589E5704EB42Q36217219-85294AC4-5AAF-43CF-9A2D-E15C81DF810AQ36315611-8D369EB0-CD9C-429D-AFA1-587119B6AA3EQ36382976-F3DA783B-15E7-4E65-A29F-6B8E14B7F358Q36852958-83F72892-C64F-47B8-BC55-2FD9139C9803Q36854395-044F0BF9-1425-4D2F-8A01-EEB3DB89C488Q36978996-C0946677-91E8-4EA8-8243-7A837E4E0ECEQ36989931-AF711942-EE0F-4BE5-961C-6068A06A7308Q37299608-948A31F0-F00A-43C6-B382-67F1C0D4EC42Q37857765-9FE440F4-0411-4123-AD6B-F41ED5E3C020Q38040843-D93BD4A9-493E-4FF3-A6F9-4F381A77DF1AQ38550878-FF562452-84E5-441F-9FC1-1F6F1523632CQ38618949-2C7C5A7B-A7F0-488A-8472-B82C5607022CQ38715379-160A50EE-0E15-4FA9-AED1-413A9DA6C591Q38911748-3357E59F-F674-4A09-B4F9-BDEB37579939Q40339679-D19CDD59-0150-4919-A195-5ABCF95C3725Q44337636-11434E80-5496-4934-90E4-A5971CDF1156Q44340786-BAB9698F-3C81-4626-AC8D-35AE376109D4Q52578077-819B52AD-4388-4455-A4FF-DBBB37B30C05Q57097943-4D4ED5D5-CB06-469D-B0F3-493AB04AA314
P2860
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@ast
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@en
type
label
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@ast
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@en
prefLabel
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@ast
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@en
P2093
P2860
P1476
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
@en
P2093
Dehaven-Hudkins DL
Gardner CJ
P2860
P356
10.1111/J.1743-3150.2004.00555.X
P478
16 Suppl 2
P577
2004-10-01T00:00:00Z